Articles

  • 4 weeks ago | news.bloombergtax.com | Natalie Choy

    XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.

  • 4 weeks ago | news.bloomberglaw.com | Natalie Choy

    President Donald Trump calls decision by US Court of International Trade “wrong” and “political” in a Truth Social post.

  • 2 months ago | biorxiv.org | Janith A. Seneviratne |Eleanor Glancy |Natalie Choy |Clare L Crisp

    AbstractEmbryonic regulators are often re-expressed in cancers, however the functional and molecular significance of this is not always understood. The epigenetic priming factors Developmental Pluripotency Associated 2 and 4 (DPPA2/4) have crucial roles in early development and are implicated in cancer pathogenesis.

  • 2 months ago | news.bloombergtax.com | Natalie Choy

    “We are going to be announcing very shortly a major tariff on pharmaceuticals,” President Donald Trump says at a National Republican Congressional Committee Dinner. • Trump suggests that pharmaceutical companies will leave China once they hear about new tariffsTo contact the reporter on this story: in Singapore at [email protected] contact the editors responsible for this story: at [email protected]© 2025 Bloomberg L.P. All rights reserved. Used with permission.

  • 2 months ago | news.bloomberglaw.com | Natalie Choy

    “We are going to be announcing very shortly a major tariff on pharmaceuticals,” President Donald Trump says at a National Republican Congressional Committee Dinner. • Trump suggests that pharmaceutical companies will leave China once they hear about new tariffsTo contact the reporter on this story: in Singapore at [email protected] contact the editors responsible for this story: at [email protected]© 2025 Bloomberg L.P. All rights reserved. Used with permission.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →